English  |  正體中文  |  简体中文  |  總筆數 :2822924  
造訪人次 :  30092685    線上人數 :  790
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"shih j y"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 351-360 / 1137 (共114頁)
<< < 31 32 33 34 35 36 37 38 39 40 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2021-04-29T05:09:02Z EGFR mutation and lobar location of lung adenocarcinoma Tseng C.-H.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; Ho C.-C.; Hsia T.-C.; Su K.-Y.; Wu M.-F.; Chiu K.-L.; Liu C.-M.; Wu T.-C.; Chen H.-J.; Chen H.-Y.; Chang C.-S.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Lin C.-H.; Chen J.J.W.; KUAN-YU CHEN; Liao W.-Y.; Shih J.-Y.; Yu S.-L.; Yu C.-J.; Yang P.-C.; Yang T.-Y.; Chang G.-C.
臺大學術典藏 2021-04-29T05:08:57Z Outcomes of cancer therapy administered to treatment-na?ve lung cancer patients in the intensive care unit Chen Y.-F.; Lin J.-W.; Ho C.-C.; Yang C.-Y.; Chang C.-H.; Huang T.-M.; Chen C.-Y.; KUAN-YU CHEN; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2021-04-29T05:08:56Z Expression of notch gene and its impact on survival of patients with resectable non-small cell lung cancer Chen C.-Y.; Chen Y.-Y.; Hsieh M.-S.; Ho C.-C.; KUAN-YU CHEN; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2021-04-29T05:08:55Z Real-world data on prognostic factors for overall survival in EGFR mutation-positive advanced non-small cell lung cancer patients treated with first-line gefitinib Yao Z.-H.; Liao W.-Y.; Ho C.-C.; KUAN-YU CHEN; Shih J.-Y.; Chen J.-S.; Lin Z.-Z.; Lin C.-C.; Yang J.C.H.; Yu C.-J.
臺大學術典藏 2021-04-29T05:08:55Z Coexistence of the BRAF Mutation and EGFR Exon 20?Insertion in a Patient with Lung Adenocarcinoma Chang L.-C.; KUAN-YU CHEN; Shih J.-Y.; Yu C.-J.; Hsieh M.-S.
臺大學術典藏 2021-04-29T05:08:54Z Astrocyte-elevated gene-1 confers resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase expression Chen C.-Y.; Chen Y.-Y.; Chen J.J.W.; KUAN-YU CHEN; Ho C.-C.; Shih J.-Y.; Chang Y.-L.; Yu C.-J.; Yang P.-C.
臺大學術典藏 2021-04-29T05:08:54Z Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; KUAN-YU CHEN; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J.
臺大學術典藏 2021-04-29T05:08:53Z Treatment effectiveness and tolerability of afatinib at different doses in patients with EGFR-mutated lung adenocarcinoma: How low can we go? Lim C.-K.; Wei Y.-F.; Tsai M.-S.; KUAN-YU CHEN; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2021-04-29T05:08:53Z Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum Liao W.-Y.; Ho C.-C.; Tsai T.-H.; KUAN-YU CHEN; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2021-04-29T05:08:53Z Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery Yang W.-C.; Xiao F.; Shih J.-Y.; Ho C.-C.; Chen Y.-F.; Tseng H.-M.; KUAN-YU CHEN; Liao W.-Y.; Yu C.-J.; Yang J.C.-H.; Kuo S.-H.; Cheng J.C.-H.; Yang P.-C.; Hsu F.-M.

顯示項目 351-360 / 1137 (共114頁)
<< < 31 32 33 34 35 36 37 38 39 40 > >>
每頁顯示[10|25|50]項目